Adachi et al. [76] and Weder et al. [77], described in their studies increased expression of the Bcl-xL, as a marker of successful treatment of IBD and of restoration of the balance between proliferation and apoptosis of erythrocyte cells. The gene discussed is BCL2L1; the disease is inflammatory bowel disease.